Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)
Clinical trial NCT03773133 · TERMINATED
Trial details
- NCT number
- NCT03773133
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-14
- Primary completion
- 2019-10-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.